Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;19(1):68-73.
doi: 10.4103/0971-6580.94506.

A survey on polypharmacy and use of inappropriate medications

Affiliations

A survey on polypharmacy and use of inappropriate medications

Sujit Rambhade et al. Toxicol Int. 2012 Jan.

Abstract

In the past, polypharmacy was referred to the mixing of many drugs in one prescription. Today polypharmacy implies to the prescription of too many medications for an individual patient, with an associated higher risk of adverse drug reactions (ADRs) and interactions. Situations certainly exist where the combination therapy or polytherapy is the used for single disease condition. Polypharmacy is a problem of substantial importance, in terms of both direct medication costs and indirect medication costs resulting from drug-related morbidity. Polypharmacy increases the risk of side effects and interactions. Moreover it is a preventable problem. A retrospective study was carried out at Bhopal district (Capital of Madhya Pradesh, India) in the year of September-November 2009 by collecting prescriptions of consultants at various levels of health care. The tendency of polypharmacy was studied and analyzed under the various heads in the survey. Available data suggests that polypharmacy is a widespread problem, and physician, clinical pharmacists and patients are all responsible. These risks can be minimized through identifying the prevalence of this potential problem in a high-risk population and by increasing awareness among patients and healthcare professionals. Physicians and clinical pharmacists have the potential to combating this problem through a variety of interventions such as reducing the number of medications taken, reducing the number of doses taken, increasing patient adherence, preventing ADRs, improving patient quality of life and decreasing facility and drug costs.

Keywords: Adverse drug reactions; clinical survey; inappropriate medication; polypharmacy; preventions.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Graph showing data analysis and result of survey

Similar articles

Cited by

References

    1. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy. 2005;25:636–45. - PubMed
    1. Goh CR. Minimising Polypharmacy - a challenge in palliative care. Singapore Med J. 2002;43:273–5. - PubMed
    1. Nisly NL, Gryzlak BM, Zimmerman MB, Wallace RB. Dietary Supplement Polypharmacy: An Unrecognized Public Health Problem? Evid Based Complement Alternat Med. 2010;7:107–13. - PMC - PubMed
    1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States.The Slone Survey. JAMA. 2002;287:337–44. - PubMed
    1. Nolan L, O’Malley K. Prescribing for the elderly: Part 1.Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1998;36:142–9. - PubMed